nct02637284 bpc 157 Gastric pentadecapeptide body protection compound and its role in accelerating musculoskeletal soft tissue healing | Cell and Tissue Research PDF) Emerging Use of BPC-157

Travel with confidence using the HRT Travel Kit

Providing a natural energy source for vegetarians, vegans, and those with absorption issues

Patients taking warfarin, heparin, DOACs (direct oral anticoagulants), or high-dose aspirin should discuss potential interactions with their provider before starting BPC-157

Unfortunately, most insurance plans won't cover peptide therapy since it's still considered experimental medicine

Disclosure of interest: Nothing to disclose E-Posters - RECOVERY, REHABILITATION AND OUTCOME 03.00 - RECOVERY, REHABILITATION AND OUTCOME - 03.03 - PROGNOSIS AND OUTCOME AFTER STROKE P2217 - ESOC25-715 OUTCOMES OF STROKE PATIENTS ADMITTED FROM LONG TERM CARE INSTITUTIONS AND NURSING HOMES Amy Lynch 1 , Joan McCormack 2 , Olga Brych 2 , Rnn Collins 3 , Tim Cassidy 2,4 , Joseph Harbison 1,2,5 1 St James's Hospital, Dublin, Ireland, 2 Irish National Audit of Stroke, National Office for Clinical Audit, Dublin 2, Ireland, 3 The National Clinical Programme for Stroke, Health Service executive, Dublin, Ireland, 4 St Vincent's University Hospital, Dublin 4, Ireland, 5 Trinity College Dublin, Dublin 2, Ireland Background and Aims: 3.5% of Irish people 65 years live in Long Term Care (LTC) centres